Granules India Slips 3% After USFDA Flags Foreign Subsidiary - Dollar Advisory Services : Best Research Advisory Firm

Breaking

Thursday, August 22, 2019

Granules India Slips 3% After USFDA Flags Foreign Subsidiary

best stock advisory in indore, commodity advisory firm, dollar advisory company, indore advisory, research advisory firm, sebi register advisory firm in indore, top 10 advisory firm in indore,
Shares of Granules India shed nearly 3% intraday on August 22 after the company received 2 observations from USFDA. United States Food and Drug Administration (USFDA) has completed inspection of the facility of Granules Pharmaceuticals Inc, a wholly-owned foreign subsidiary of the company located in Virginia, USA on August 21, with two minor observations. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period. 

Get a Free Trial from Dollar Advisory


Call Us: 9111179961

No comments:

Post a Comment